SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AG 1024 | 65678-07-1 | sc-205907 | 1 mg | $105.00 | 22 | |
This compound is known to inhibit the insulin receptor and has been used in research to understand insulin-related pathways. | ||||||
Hypericin | 548-04-9 | sc-3530 sc-3530A | 1 mg 5 mg | $65.00 $210.00 | 11 | |
Hypericin (CAS 548-04-9) is a chemical compound that acts as an inhibitor of insulin receptor (R). It affects the insulin signaling pathway without invoking any potential medical applications. | ||||||
BMS-536924 | 468740-43-4 | sc-507397 | 5 mg | $285.00 | ||
This is a small molecule insulin receptor inhibitor that has shown potential in inhibiting insulin signaling pathways. | ||||||
HNMPA-(AM)3 | 120944-03-8 | sc-221730 | 5 mg | $186.00 | 12 | |
HNMPA-(AM)3 (CAS 120944-03-8) is a chemical compound known for its role as an inhibitor of insulin receptor (IR). It interacts with the insulin receptor, modulating its activity through specific mechanisms. This compound's impact on insulin receptor function has been extensively studied in various contexts. | ||||||
HNMPA | 120943-99-9 | sc-205714 sc-205714A | 5 mg 25 mg | $97.00 $386.00 | 11 | |
HNMPA (CAS 120943-99-9) is a chemical compound known for its role as an inhibitor of insulin R. It interacts with insulin receptors, modulating their activity. This compound's mechanism of action involves interference with insulin receptor function, affecting cellular signaling pathways. It is extensively studied for its effects on insulin-related processes. | ||||||
AGL 2263 | sc-221223 | 5 mg | $350.00 | 1 | ||
AGL 2263 is a chemical compound known for its role as an inhibitor of insulin receptor (R). It modulates insulin signaling pathways, impacting cellular responses. The compound's actions are of interest due to their effects on insulin-related processes. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $150.00 $455.00 | 20 | |
5-Iodotubercidin (CAS 24386-93-4) is a chemical compound known for its role as an inhibitor of insulin receptor (R). It affects the insulin signaling pathway, exerting an impact on cellular processes. The compound's interaction with the insulin receptor has implications for various biological functions. | ||||||
GSK1838705A | 1116235-97-2 | sc-364502 sc-364502A | 5 mg 50 mg | $240.00 $992.00 | ||
An investigational drug that acts as an insulin receptor kinase inhibitor, potentially offering therapeutic benefits for diabetes and related conditions. | ||||||
Linsitinib | 867160-71-2 | sc-396762 sc-396762A | 5 mg 10 mg | $143.00 $260.00 | 1 | |
An inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) that has been studied for its potential in cancer therapy. | ||||||
BMS-754807 | 1001350-96-4 | sc-507396 | 5 mg | $304.00 | ||
Another IGF-1R inhibitor that has shown promise in laboratory studies for its anti-tumor effects. | ||||||